Lenz Therapeutics Inc (LENZ)

Operating Cash Flow (Statement)

-$113.91M

TTM · Period ending: · USD

LENZ logo

LENZ Operating Cash Flow (Statement)

Latest reported-$113.91M
LENZ TTM Cash from Operations (-$28.07M → -$113.91M)
High-resolution chart · PNG

LENZ operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lenz Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-113,908,000
-86,703,000
-69,170,000
-45,223,000
-47,216,000
-51,503,000
-59,391,000
-71,283,000
-73,790,000
-63,243,000
-52,104,000
-38,597,000
-47,726,000
-64,572,000
-73,014,000
-81,144,000
-74,342,000
-66,032,000
-52,852,000
-42,530,000
-28,068,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.